I agree that this site is using cookies. You can find further informations here.
X
Vande Casteele, N
253  results:
Search for persons X
?
1

OP40 Transcriptomic signature of response to vedolizumab in..:

Linggi, B ; Salas, A ; Veny, M...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i71-i71 , 2024
Link: https://doi.org/10.1093/..
 
?
2

P928 "Metabolism and Response to Stress" (MARS) gene signat..:

Linggi, B ; Sangiorgi, B ; Smith, M I...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1687-i1688 , 2024
Link: https://doi.org/10.1093/..
 
?
3

DOP35 Spatial transcriptomics reveals cellular niches assoc..:

Battat, R ; Sangiorgi, B ; Linggi, B...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i135-i136 , 2024
Link: https://doi.org/10.1093/..
 
?
4

P479 Reliability and responsiveness of histologic disease a..:

Solitano, V ; Schaeffer, D F ; Hogan, M...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i608-i609 , 2023
Link: https://doi.org/10.1093/..
 
?
5

P306 MORF-057, an oral selective α4β7 integrin inhibitor fo..:

Ray, A ; Cui, D ; Lee, D...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S333-S335 , 2021
Link: https://doi.org/10.1093/..
 
?
6

P540 GB004, a novel prolyl hydroxylase inhibitor for inflam..:

Levesque, B ; Taylor Meadows, K ; Buch, A...
Journal of Crohn's and Colitis.  14 (2020)  Supplement_1 - p. S461-S462 , 2020
Link: https://doi.org/10.1093/..
 
?
7

P120 Prevalence of endoscopic improvement and endoscopic re..:

Dulai, P ; Singh, S ; Jairath, V...
Journal of Crohn's and Colitis.  14 (2020)  Supplement_1 - p. S196-S196 , 2020
Link: https://doi.org/10.1093/..
 
?
8

DOP45 Adequate infliximab exposure during the induction pha..:

Vande Casteele, N ; Papamichael, K ; Jeyarajah, J..
Journal of Crohn's and Colitis.  13 (2019)  Supplement_1 - p. S053-S054 , 2019
Link: https://doi.org/10.1093/..
 
?
9

P485 Prediction Model Incorporating Pharmacokinetics Calcul..:

Vande Casteele, N ; Jairath, V ; Jeyarajah, J...
Journal of Crohn's and Colitis.  13 (2019)  Supplement_1 - p. S354-S355 , 2019
Link: https://doi.org/10.1093/..
 
?
10

P631 Development and validation of a clinical scoring tool ..:

Dulai, P S ; Singh, S ; Vande Casteele, N...
Journal of Crohn's and Colitis.  13 (2019)  Supplement_1 - p. S433-S433 , 2019
Link: https://doi.org/10.1093/..
 
?
11

High body mass index is associated with increased risk of t..:

Kurnool, S. ; Nguyen, N. H. ; Proudfoot, J....
Alimentary Pharmacology & Therapeutics.  47 (2018)  11 - p. 1472-1479 , 2018
Link: https://doi.org/10.1111/..
 
?
12

Systematic review with meta‐analysis: endoscopic and histol..:

Ma, C. ; Guizzetti, L. ; Panaccione, R....
Alimentary Pharmacology & Therapeutics.  47 (2018)  12 - p. 1578-1596 , 2018
Link: https://doi.org/10.1111/..
 
?
13

P246 The association of serum 7α-hydroxy-4-cholesten-3-one ..:

Battat, R ; Duijvestein, M ; Vande Casteele, N...
Journal of Crohn's and Colitis.  12 (2018)  supplement_1 - p. S224-S225 , 2018
Link: https://doi.org/10.1093/..
 
?
14

Editorial: variability in adalimumab trough and peak serum ..:

Vande Casteele, N. ; Gils, A.
Alimentary Pharmacology & Therapeutics.  45 (2017)  11 - p. 1475-1476 , 2017
Link: https://doi.org/10.1111/..
 
?
15

Exposure‐response relationship of certolizumab pegol induct..:

Vande Casteele, N. ; Feagan, B. G. ; Vermeire, S....
Alimentary Pharmacology & Therapeutics.  47 (2017)  2 - p. 229-237 , 2017
Link: https://doi.org/10.1111/..
 
1-15